✦ LIBER ✦

Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization

✍ Scribed by James C Stringham; David A Bull; Thomas C Fuller; Abdallah G Kfoury; David O Taylor; Dale G Renlund; S.V Karwande

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The contribution of blood product transf

✍ S.G Drakos; J.C Stringham; J.W Long; T.C Fuller; K.E Nelson; J.M Lindblom; P.A M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Low-dose prophylactic intravenous immuno

✍ S.G Drakos; J.W Long; J.C Stringham; T.C Fuller; B.A Campbell; S.S Schmitz; K.E 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Allosensitization and LVAD: it’s in the

✍ Myra Coppage; Neil Blumberg; Leway Chen; Todd Massey; Jean Heuther; Martin Zand; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 22 KB

Abolishment of HLA Allosensitization in

✍ Myra Coppage; Marc L. Baker; Leway Chen; Lawrence Fialkow; Kelly Gettings; Danie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Prevalence and risks of allosensitizatio

✍ Stavros G. Drakos; James C. Stringham; James W. Long; Edward M. Gilbert; Thomas 📂 Article 📅 2007 🏛 CTSNet 🌐 English ⚖ 502 KB

Lack of significant de novo HLA allosens

✍ Myra Coppage; Marc Baker; Lawrence Fialkow; Danielle Meehan; Kelly Gettings; Lew 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 277 KB